Transient elastography devices are used for liver fibrosis and cirrhosis evaluation in patients through non-invasive liver elastography examination. The devices provide a simple, rapid and reproducible measurement of liver stiffness which is an accurate index of liver fibrosis. This helps in avoiding unnecessary liver biopsies which are an invasive procedure.

The global Transient Elastography Devices Market is estimated to be valued at US$ 89.13 Mn in 2023 and is expected to exhibit a CAGR of 1.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growing demand for accurate and non-invasive diagnosis of liver diseases is a key trend driving the transient elastography devices market. Liver fibrosis and cirrhosis are asymptomatic in early stages, therefore non-invasive techniques for diagnosis have gained prominence. Transient elastography enables rapid and simple measurement of liver stiffness through shear wave imaging, giving it an advantage over liver biopsy which is an invasive procedure. The risks and complications of biopsy can be avoided through use of transient elastography devices which provide a clear diagnosis of liver diseases in outpatient settings. This has increased adoption of transient elastography among healthcare providers for evaluation of liver fibrosis and cirrhosis.

SWOT Analysis
Strength: Transient elastography can easily quantify liver steatosis, fibrosis staging and detect cirrhosis non-invasively without risk of complications; The procedure is quick, painless and reproducible.
Weakness: Operator dependency and lack of standardization; Accuracy can be limited in obese patients or those with ascites.
Opportunity: Rising prevalence of chronic liver diseases worldwide; Increasing awareness about early liver disease diagnosis.
Threats: High cost of devices limits widespread adoption in low and middle-income countries; Alternative imaging modalities like MRI gaining traction.

Key Takeaways

The Global Transient Elastography Devices Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global Transient Elastography Devices Market is estimated to be valued at US$ 89.13 Mn in 2023 and is expected to exhibit a CAGR of 1.9% over the forecast period 2023 to 2030.

Regional analysis comprises Asia Pacific region is expected to dominate the global transient elastography devices market during the forecast period. This is attributed to high prevalence of viral hepatitis and rising healthcare expenditure in emerging economies such as India and China. The region is also expected to witness highest growth rate over the forecast period.

Key players operating in the transient elastography devices market are Echosens, HISKY Medical Technologies Co., Ltd. and SMEDA Medical Co., Ltd. Echosens is a global leader in liver fibrosis and steatosis assessment and holds largest market share. The company offers FibroScan, a patented and validated. HISKY Medical Technologies and SMEDA Medical are other prominent players focusing on R&D to develop low-cost devices for broader reach.

For More details on the topic:

https://www.rapidwebwire.com/transient-elastography-devices-market-size-market-share-analysis/